Medtronic Statistics

Total Valuation

Medtronic has a market cap or net worth of EUR 110.43 billion. The enterprise value is 128.53 billion.

Market Cap	110.43B
Enterprise Value	128.53B

Important Dates

The last earnings date was Tuesday, February 18, 2025.

Earnings Date	Feb 18, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.53%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.28B

Valuation Ratios

The trailing PE ratio is 27.26.

PE Ratio	27.26
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.75, with an EV/FCF ratio of 24.72.

EV / Earnings	31.72
EV / Sales	4.05
EV / EBITDA	13.75
EV / EBIT	19.69
EV / FCF	24.72

Financial Position

The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.54.

Current Ratio	1.90
Quick Ratio	1.19
Debt / Equity	0.54
Debt / EBITDA	2.72
Debt / FCF	4.87
Interest Coverage	9.01

Financial Efficiency

Return on equity (ROE) is 8.44% and return on invested capital (ROIC) is 5.56%.

Return on Equity (ROE)	8.44%
Return on Assets (ROA)	4.72%
Return on Invested Capital (ROIC)	5.56%
Return on Capital Employed (ROCE)	8.73%
Revenue Per Employee	332,374
Profits Per Employee	42,649
Employee Count	95,000
Asset Turnover	0.37
Inventory Turnover	2.02

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.07% in the last 52 weeks. The beta is 0.86, so Medtronic's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	+8.07%
50-Day Moving Average	82.93
200-Day Moving Average	79.41
Relative Strength Index (RSI)	52.32
Average Volume (20 Days)	1,574

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.07

Income Statement

In the last 12 months, Medtronic had revenue of EUR 31.58 billion and earned 4.05 billion in profits. Earnings per share was 3.11.

Revenue	31.58B
Gross Profit	20.70B
Operating Income	6.49B
Pretax Income	4.97B
Net Income	4.05B
EBITDA	9.03B
EBIT	6.49B
Earnings Per Share (EPS)	3.11

Full Income Statement

Balance Sheet

The company has 7.53 billion in cash and 25.31 billion in debt, giving a net cash position of -17.77 billion.

Cash & Cash Equivalents	7.53B
Total Debt	25.31B
Net Cash	-17.77B
Net Cash Per Share	n/a
Equity (Book Value)	47.19B
Book Value Per Share	36.60
Working Capital	10.15B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.94 billion and capital expenditures -1.74 billion, giving a free cash flow of 5.20 billion.

Operating Cash Flow	6.94B
Capital Expenditures	-1.74B
Free Cash Flow	5.20B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 65.57%, with operating and profit margins of 20.55% and 12.83%.

Gross Margin	65.57%
Operating Margin	20.55%
Pretax Margin	15.73%
Profit Margin	12.83%
EBITDA Margin	28.61%
EBIT Margin	20.55%
FCF Margin	16.47%

Dividends & Yields

This stock pays an annual dividend of 2.59, which amounts to a dividend yield of 3.01%.

Dividend Per Share	2.59
Dividend Yield	3.01%
Dividend Growth (YoY)	2.05%
Years of Dividend Growth	1
Payout Ratio	84.62%
Buyback Yield	2.53%
Shareholder Yield	5.54%
Earnings Yield	3.67%
FCF Yield	4.71%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medtronic has an Altman Z-Score of 2.88. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.88
Piotroski F-Score	n/a